Bremelanotide: Shaping the Future of Female Sexual Health
Bremelanotide, also known by its trade name Vyleesi, is a medication approved by the Food and Drug Administration (FDA) for the treatment of hypoactive sexual desire disorder (HSDD) in premenopausal women. It functions by activating melanocortin receptors and is known for its application in addressing issues related to sexual arousal. The journey of Bremelanotide fromอ่านเพิ่มเติม